Back |
home / stock / ckpt / ckpt message board
Subject | By | Source | When |
---|---|---|---|
Tax loss selling ... not seen the end | Monroe1 | investorshub | 12/08/2022 10:17:03 PM |
We have a 30 million dollar cap now | vein | investorshub | 12/08/2022 9:35:31 PM |
Come on now | vein | investorshub | 12/08/2022 9:34:52 PM |
$.71? | chainma1l | investorshub | 12/08/2022 9:06:56 PM |
Someone call the bottom please !! | vein | investorshub | 12/08/2022 8:50:26 PM |
unless they have something up the sleeve I | Monroe1 | investorshub | 12/07/2022 1:03:53 AM |
10+ bagger necessary at this point. That | chainma1l | investorshub | 12/06/2022 10:54:18 PM |
I am hoping we have found a bottom soon | vein | investorshub | 12/06/2022 8:41:56 PM |
Ha Im just lookin to get my dam | vein | investorshub | 12/06/2022 8:27:50 PM |
Not currently. I sold at a slight | chainma1l | investorshub | 12/06/2022 7:31:45 PM |
You have any shares left chainma? | vein | investorshub | 12/06/2022 6:23:37 PM |
PROBABLY a good investment at some point, but | chainma1l | investorshub | 12/06/2022 5:29:49 PM |
znewcar1: CKPT 17% v2,1M c3.18 f67,8M H3.26 S3 | znewcar1 | investorshangout | 01/12/2021 9:26:11 PM |
znewcar1: CKPT 19% v5,3M c3.91 f60,0M H4.32 S3.75 | znewcar1 | investorshangout | 09/15/2020 8:39:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Checkpoint Therapeutics Inc. Company Name:
CKPT Stock Symbol:
NASDAQ Market:
Checkpoint Therapeutics Inc. Website:
WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has entered into a definitive agreement with a single healthcare-dedicated institutional in...
WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has completed the resubmission of its Biologics License Application (“BLA”) t...
WALTHAM, Mass., June 24, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has reached alignment with the Food and Drug Administration (“FDA”) on its bi...